October 5, 2015 / 4:12 PM / 2 years ago

BUZZ-Cipher Pharmaceuticals Inc: Settles patent litigation

** Canadian drug developer's U.S.-listed shares up 15 pct at $4.50; Toronto-listed shares up 15.4 pct at C$6

** Company, along with Sun Pharma's unit Ranbaxy Pharmaceuticals Inc and Galephar Pharmaceutical Research Inc, settles patent litigation with Actavis, which is now Allergan Plc

** Under the agreement, Actavis, which merged with Allergan in March, can sell generic version of acne drug Absorica about 9 months before its patent expires in Sept. 2021

** Up to Friday's close, stock had fallen nearly 73 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below